Worldwide DNA testing market was valued at USD 6,200 in 2014. Increasing infectious, genetic and chronic diseases worldwide are the key factors influencing the industry growth. Primary revenue causing activity in the industry revolves DNA profiling intended for enhanced understanding the inclination for diseases and probable adverse reactions going on with obtainable and /or /under clinical expansion drugs.
DNA identification and augmenting implementation of personalized medicine applications to cure chronic disease are few factors anticipated to boost the market growth. Furthermore, next generation diagnosing and testing solutions is a result for high advancement technology which will impact the overall industry.
Full research report on Global Minimally Invasive Surgery Market Analysis:
Rising application of biobanking services involving DNA diagnostics/ testing as a vital trend for cord blood banking, coupled with augmenting demand for pre- natal and newborn screening detecting congenital abnormalities will enhance the overall market demand further.
Based on technology, the overall market is segmented into ISH diagnostics, NGS DNA diagnosis and microarray and PCR based diagnostics. In 2014, PCR based diagnostics led the market owing to the high availability and widespread market usage of the product owing to the existence of momentous number of market participants in the segment. NGS based diagnostics is expected to undergo significant growth over the coming years mainly owing to breakthrough and innovative developments. Analysis of efficient data coupled with rapid and highly accurate diagnosis is leading towards the overall industry growth.
Request for sample of this research report:
Newborn genetic screening, identity diagnostics forensics, pre-implantation diagnosis and new born genetic screening are the key applications in the market. Clinical conformation and use of DNA testing methods in infection disease diagnosis has resulted in maximum revenue generation among application segments owing to availability of several products in the market for disease like MRSA, HIV, CT/NG,HBV and TB.
In 2014, North America led the DNA testing market. The region contributed for over 2,000 million market share. Sturdy government initiatives, proactive funding for DNA testing research and existence of sophisticated healthcare infrastructure will drive the DNA testing market. Asia Pacific is projected to experience high growth of over 7% from 2014 to 2022 owing to growing incentives presented by government in emerging countries. Also, rising incidence of chronic disease results in augmented accessibility of aimed population, this will impact the regional growth positively.
View more reports of this category by Grand View Research at:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States